Get the Stockscreener App
7.71
0.77%
-0.06
Replimune Group Inc stock is traded at $7.71, with a volume of 1.35M.
It is down -0.77% in the last 24 hours and up +5.47% over the past month.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
See More
Previous Close:
$7.77
Open:
$7.77
24h Volume:
1.35M
Relative Volume:
1.64
Market Cap:
$770.92M
Revenue:
-
Net Income/Loss:
$-209.96M
P/E Ratio:
-2.4399
EPS:
-3.16
Net Cash Flow:
$-176.27M
1W Performance:
-22.98%
1M Performance:
+5.47%
6M Performance:
-38.02%
1Y Performance:
+14.56%
1-Day Range:
$7.63
$8.54
1-Week Range:
$6.93
$10.30
52-Week Range:
$4.92
$17.00
Replimune Group Inc Stock (REPL) Company Profile
Name
Replimune Group Inc
Sector
Industry
Phone
(781) 222-9600
Address
500 UNICORN PARK, WOBURN, MA
Compare REPL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REPL
Replimune Group Inc
|
7.71 | 770.92M | 0 | -209.96M | -176.27M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Replimune Group Inc Stock (REPL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | ROTH MKM | Buy |
| Apr-17-23 | Resumed | Piper Sandler | Overweight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Nov-17-20 | Initiated | BTIG Research | Buy |
| Nov-02-20 | Initiated | Jefferies | Buy |
| Oct-15-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-01-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-05-20 | Initiated | Barclays | Overweight |
| Sep-04-19 | Initiated | ROTH Capital | Buy |
| Jul-23-19 | Initiated | Chardan Capital Markets | Buy |
| Jul-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-08-19 | Initiated | H.C. Wainwright | Buy |
| Apr-25-19 | Initiated | Wedbush | Outperform |
| Jan-23-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-14-18 | Initiated | JP Morgan | Overweight |
| Aug-14-18 | Initiated | Leerink Partners | Outperform |
View All
Replimune Group Inc Stock (REPL) Latest News
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | REPL Stock News - GuruFocus
Brokerages Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $19.43 - Defense World
Replimune Group (REPL) Projected to Post Earnings on Thursday - Defense World
MetLife Investment Management LLC Raises Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
(REPL) On The My Stocks Page - news.stocktradersdaily.com
Invesco Ltd. Sells 92,952 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Perhaps timely catching Replimune Group Inc (REPL) would be a good idea - Sete News
A stock that deserves closer examination: Replimune Group Inc (REPL) - uspostnews.com
XTX Topco Ltd Purchases New Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Wells Fargo & Company MN - Defense World
Potential Price Increase for Replimune Group Inc (REPL) After Recent Insider Activity - knoxdaily.com
Market Insights: Replimune Group Inc (REPL)’s Notable Gain of 2.43, Closing at 9.27 - DWinneX
Legal & General Group Plc Has $719,000 Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune: Scope Goes Beyond That Of RP1 Oncolytic Targeting For Melanoma (NASDAQ:REPL) - Seeking Alpha
Are Replimune Group Inc’shares a good deal? - uspostnews.com
Market Momentum Report: Replimune Group Inc (REPL)’s Positive Close at 8.83 - DWinneX
A Detailed Analysis Of Replimune Group Inc (REPL) - Marketing Sentinel
Could The Upcoming FDA Decision Ignite Investor Confidence In REPL? - RTTNews
Replimune Group Inc (REPL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Benzinga
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Has $5.89 Million Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Alliancebernstein L.P. Sells 48,397 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Vanguard Group Inc. Has $43.55 Million Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA - MSN
Sei Investments Co. Purchases New Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune stock target raised to $22 at H.C. Wainwright - MSN
Navigating Uncertainty: Replimune Group’s Strategic Challenges Amid Clinical Trials and Global Risks - MSN
Is Replimune Group (NASDAQ:REPL) A Risky Investment? - simplywall.st
Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Rating of “Buy” from Analysts - Defense World
KLP Kapitalforvaltning AS Takes Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Corebridge Financial Inc. Reduces Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Stake Lifted by American Century Companies Inc. - Defense World
Teacher Retirement System of Texas Takes $189,000 Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group (NASDAQ:REPL) Trading Down 7.6%What's Next? - MarketBeat
SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy - The Manila Times
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Swiss National Bank - Defense World
Charles Schwab Investment Management Inc. Has $6.16 Million Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Victory Capital Management Inc. Purchases Shares of 44,880 Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Bank of New York Mellon Corp Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Holdings Cut by AlphaQuest LLC - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Receives $19.43 Average Price Target from Analysts - Defense World
Arizona State Retirement System Invests $156,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Financial Metrics Check: Replimune Group Inc (REPL)’s Ratios for Trailing Twelve Months - The Dwinnex
Replimune Group Appoints New Director, Grants Stock Options By Investing.com - Investing.com Australia
Replimune Group Appoints New Director, Grants Stock Options - Investing.com
Replimune Group Appoints Michael Goller To Board, Increases Board Size To Ten -March 07, 2025 at 05:04 pm EST - Marketscreener.com
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) -March 07, 2025 at 04:11 pm EST - Marketscreener.com
Rhumbline Advisers Grows Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Raises $55 Million To Advance Its Oncolytic Immunotherapy Programs - Bain Capital
Replimune Group Inc Stock (REPL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):